HLB Pharmaceutical Co Ltd
KOSDAQ:047920
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HLB Pharmaceutical Co Ltd
KOSDAQ:047920
|
KR |
|
Royal Helium Ltd
XTSX:RHC
|
CA |
|
Readly International AB (publ)
F:5GS1
|
SE |
|
Ambarella Inc
NASDAQ:AMBA
|
US |
|
A
|
AYRO Inc
F:WR4F
|
US |
|
Old Market Capital Corp
OTC:OMCC
|
US |
|
LandBridge Co LLC
NYSE:LB
|
US |
|
P
|
Princeton Technology Corp
TPEX:6129
|
TW |
|
Midatech Pharma PLC
LSE:MTPH
|
UK |
|
E
|
Eko-Oze SA
WSE:EKE
|
PL |
|
E
|
ERG SpA
XMUN:ER9
|
IT |
|
Eviso SpA
F:6Z8
|
IT |
|
M
|
Milton Essex SA
WSE:MTN
|
PL |
|
MegaPower Makmur Tbk PT
IDX:MPOW
|
ID |
|
Merit Group PLC
F:HXP0
|
UK |
Shareholder Yield
Current shareholder yield for HLB Pharmaceutical Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
HLB Pharmaceutical Co Ltd
| Average Annual Return | 8.85% |
| Standard Deviation of Annual Returns | 50.74% |
| Max Drawdown | -85% |
| Market Capitalization | 286.7B KRW |
| Shares Outstanding | 32 800 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
HLB Pharmaceutical Co Ltd's latest stock split occurred on Aug 4, 2026
The company executed a 446-for-411 stock split, meaning that for every 411 shares held, investors received 446 new shares.
Before the split, HLB Pharmaceutical Co Ltd traded at 8280.003 per share. Afterward, the share price was about 8240.
The adjusted shares began trading on Aug 4, 2026. This was stock split number 2 in HLB Pharmaceutical Co Ltd's history, following the previous one in Apr 12, 2016.
